Last updated on June 2020

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers


Brief description of study

The primary objective of this study is to describe the safety profile of MenACYW conjugate vaccine and MENVEO when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers

Detailed Study Description

Study duration per participant is approximately 16 months, which includes a safety follow-up contact at 6 months after the final vaccination

Clinical Study Identifier: NCT03673462

Find a site near you

Start Over

Investigational Site Number 6300108

San Juan, Puerto Rico
2.64miles
  Connect »

Investigational Site Number 6300014

San Juan, Puerto Rico
4.34miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.